ATP2C1 and breast cancer: Additionally, the secretory pathway Ca2+ ATPase I (SPCA1, ATP2C1) is highly expressed in basal-like BCs, and silencing SPCA1 in the basal-like BC cell line MDA-MB-231 leads to reduced proliferation.